Gano Kyle sold NBIX
November 4, 2025 · Form 4 insider transaction
Gano Kyle sold 300 shares of Neurocrine Biosciences, Inc. at $141.97 per share, a transaction worth $42.6K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 0 days after the transaction.
Direction
Disposed (sell-side)
Shares
300
Price
$141.97
Total value
$42.6K
InsiderGano Kyle
Role—
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateNovember 4, 2025
Filing dateNovember 4, 2025
Shares owned after140,407
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
The mandatory sales reported in this Form 4 were made to cover withholding taxes and tax related items imposed by the Issuer in connection with the vesting of restricted stock units, and it is intended to comply with the requirements of Rule 10b5-1(c)(1)(i)(B) under the Exchange Act and be interpreted to meet the requirements of Rule 10b5-1(c).